Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

RyCarma Therapeutics, Inc., formerly known as ARMGO Pharma (the "Company" or "RyCarma"), a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and ...

City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced the appointment of Andrew "Andy" Orth as chief executive officer and ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several ...

This study addresses fundamental questions surrounding otitis media effusion in Down syndrome, identifying DYRK1A as a key gene involved in the condition. The findings are compelling, highlighting ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

A team at the University of Calgary is making scientific advances in understanding plant adaptation, which could ultimately be used to find ways to make agricultural crops more resilient to heat ...

Using computers to make a digital replica of the heart—a digital heart twin—can successfully identify problem areas deep in ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...

Alnylam's TTR franchise, powered by Amvuttra, poised for $7.5B peak revenue with undervalued shares and long-term growth ...

The division, which will expand on the already-existing Released Soldiers’ Division and Fund, will include a dedicated branch for reservists’ welfare and be led by Col. (res.) Eyal Hans ...

Justin Trudeau announced Monday that he was also stepping down as leader of Canada’s Liberal Party. He will remain in both roles until a replacement is chosen. By Matina Stevis-GridneffIan ...